We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$158B
AUM Growth
-$60B
Cap. Flow
-$70.1B
Cap. Flow %
-44.4%
Top 10 Hldgs %
24.44%
Holding
5,371
New
314
Increased
1,955
Reduced
1,669
Closed
872

Sector Composition

Rank Sector Weight
1 Technology 28.28%
2 Healthcare 11.27%
3 Financials 10.52%
4 Consumer Discretionary 10.12%
5 Communication Services 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMTK
4226
DELISTED
DermTech, Inc. Common Stock
DMTK
$252 ﹤0.01%
97
BTTX
4227
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$251 ﹤0.01%
+232
New +$224
ISPO
4228
DELISTED
Inspirato
ISPO
$244 ﹤0.01%
12
-626
-98% -$11.3K
BVN icon
4229
Compañía de Minas Buenaventura
BVN
$7.69B
$243 ﹤0.01%
33
BBLN
4230
DELISTED
Babylon Holdings Limited
BBLN
$243 ﹤0.01%
3,347
+1,109
+50% +$3.81K
TLPH icon
4231
Talphera
TLPH
$66.4M
$241 ﹤0.01%
+217
New +$190
HHLA.WS
4232
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$200 ﹤0.01%
10,000
AGQ icon
4233
ProShares Ultra Silver
AGQ
$1.15B
$189 ﹤0.01%
7
BOLT icon
4234
Bolt Biotherapeutics
BOLT
$7.67M
$178 ﹤0.01%
7
SDACW
4235
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$171 ﹤0.01%
5,714
ABSI icon
4236
Absci
ABSI
$1.32B
$169 ﹤0.01%
111
-26,775
-100% -$43.1K
HEPA
4237
DELISTED
Hepion Pharmaceuticals
HEPA
0
EDUC icon
4238
Educational Development Corp
EDUC
$11.8M
$163 ﹤0.01%
+137
New +$234
JDST icon
4239
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$31.6M
0
CORN icon
4240
Teucrium Corn Fund
CORN
$176M
$155 ﹤0.01%
7
QNCX icon
4241
Quince Therapeutics
QNCX
$22.9M
$151 ﹤0.01%
1
GB
4242
DELISTED
Global Blue Group Holding
GB
$146 ﹤0.01%
+30
New +$160
DYAI icon
4243
Dyadic International
DYAI
$38.3M
$139 ﹤0.01%
72
UPH
4244
DELISTED
UpHealth, Inc.
UPH
$139 ﹤0.01%
74
+57
+335% +$94
FBIO icon
4245
Fortress Biotech
FBIO
$104M
$136 ﹤0.01%
+16
New +$158
NGNE icon
4246
Neurogene
NGNE
$656M
$135 ﹤0.01%
8
-257
-97% -$4.21K
SRS icon
4247
ProShares UltraShort Real Estate
SRS
$15.3M
$135 ﹤0.01%
2
CBIO
4248
Crescent Biopharma
CBIO
$537M
$132 ﹤0.01%
1
AUDC icon
4249
AudioCodes
AUDC
$244M
$128 ﹤0.01%
14
-20
-59% -$197
BZFD icon
4250
BuzzFeed
BZFD
$99M
$123 ﹤0.01%
+61
New +$165

Similar funds

Barclays's Q2 2023 Portfolio in Review

As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.

  • Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
  • Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
  • Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
  • Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
  • Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
  • Barclays opened 314 new positions and closed 872 in Q2 2023.
  • Barclays's portfolio value fell 28% quarter-over-quarter to $158B.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.